Challenges in managing graft-versus-host disease in developing countries: a perspective

Bone Marrow Transplantation
Muhammad Sabih SaleemShahrukh K Hashmi

Abstract

Hematopoietic cell transplant (HCT) activity is increasing worldwide due to safer techniques, widening indications, and more availability of donors. New HCT centers have recently been established in many developing countries including Asian and African countries. Due to limited resources, logistic, political, and social issues in developing countries, the treatment of orphan diseases like graft-versus-host disease (GVHD) can be challenging. We intended to delineate the current issues that institutions and clinicians face in managing GVHD. We conducted a comprehensive systematic electronic review of peer-reviewed published articles on GVHD management in developing countries. We used PubMed, Cochrane, and Embase databases as our primary source of data. Studies that were included described the treatments for both acute and chronic GVHD. Consensus on the use of high-dose methyl-prednisone and prednisolone as the initial therapy was widely accepted and used in practice. Socio-economic factors were found to be the major factor involved in GVHD management in lower income patients. Delayed diagnosis and treatment, lack of availability of healthcare professionals, lack of knowledge among cancer patients, and poverty are major concerns i...Continue Reading

References

Mar 1, 1991·Clinical Oncology : a Journal of the Royal College of Radiologists·A T Ajekigbe
Jul 31, 1982·Lancet·E D ThomasR Storb
Aug 1, 1980·The American Journal of Medicine·H M ShulmanE D Thomas
Mar 1, 1997·Current Opinion in Oncology·D C Marcellus, G B Vogelsang
Oct 14, 1998·American Journal of Respiratory and Critical Care Medicine·M S IpR H Liang
May 18, 2001·Nature·F R Appelbaum
Jun 5, 2003·World Journal of Surgery·Abdullah Noor Hisham, Cheng Har Yip
Sep 17, 2003·European Journal of Epidemiology·Imtiaz A Malik, Sethuraman Gopalan
Sep 10, 2005·Bone Marrow Transplantation·A GratwohlUNKNOWN Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Mar 28, 2007·World Journal of Surgery·Gaurav AgarwalPolly S Y Cheung
Sep 25, 2008·Bone Marrow Transplantation·Ts ShamsiS Ansari
Jul 27, 2010·Blood·Mark CrowtherMark A Crowther
Jan 18, 2011·Hematology·Emanuele Angelucci
Jan 10, 2012·Cancer·Adi J PriceRobert W Ryder
Nov 1, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Parinda A Mehta, Lawrence B Faulkner
Sep 30, 2014·Bone Marrow Transplantation·N RandallC Ustun
Dec 17, 2014·Annals of Global Health·Cherian VargheseHai-Rim Shin
Dec 19, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·W-C FanC-H Chiang
Aug 1, 2015·Nigerian Medical Journal : Journal of the Nigeria Medical Association·Antonella IsgròGuido Lucarelli
Nov 23, 2016·Mediterranean Journal of Hematology and Infectious Diseases·Hosein Kamranzadeh FumaniArdeshir Ghavamzadeh
Aug 2, 2017·Hematology/oncology and Stem Cell Therapy·Parvez AhmedTariq Ghafoor

❮ Previous
Next ❯

Citations

Apr 25, 2020·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Yuchun YanWen He
Aug 8, 2019·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Ajay SharmaVikram Mathews

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.